India should reduce import tariffs: USTR
Neha Dewan | @TheDollarBiz USA is a top export destination for India and accounts for around 8% of India's total trade The US Trade Representative (USTR), Ambassador Michael Froman, has urged the Indian government to review its Intellectual Property Rights (IPR) as concerns over IPR violations threaten to disrupt India’s exports to USA. Ambassador Froman is in India for the US-India Trade Policy Forum which he co-chaired with India’s Commerce Minister Nirmala Sitharaman on November 25, 2014. During the forum, Ambassador Froman urged the Indian government to reduce import tariffs for off-patent drugs, and allow US companies to participate in India’s public solar energy and health insurance programmes. Last month, the USTR had initiated an Out-of-Cycle Review (OCR) of India ...
USTRs Out of Cycle Review of IPR issues in India to end in two weeks
@TheDollarBiz Every third tablet consumed in the World is ‘Made in India’ - Indian Drugs Manufacturers' Association (IDMA) As planned earlier this year, the US Trade Representative (USTR) has started an Out-of-Cycle Review (OCR) of India for its 301 paper (Section 301 of the US Trade Act of 1974) which has India on a “Priority Watch List” on issues concerning protection of US Intellectual Property Rights (IPR) in India. The first 301 report, then called a “Fact Sheet,” was published in 1989 and had eight countries on the "Priority Watch List" and 17 on the "Watch List". Since then, countries such as Italy, South Korea and the Philippines have been removed from the lists, but India remains stuck, mainly due ...
